# Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older

> **NCT00741039** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 126 (actual)

## Conditions studied

- Breast Cancer
- Lung Cancer
- Prostate Cancer

## Interventions

- **BIOLOGICAL:** inactivated influenza vaccine and the 23- valent pneumococcal vaccine
- **BIOLOGICAL:** inactivated influenza vaccine and the PPV23 vaccine (Pneumovax)

## Key facts

- **NCT ID:** NCT00741039
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2015-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00741039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00741039, "Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00741039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*